ArticleCancer research2025

Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells.

Soyoung Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.